Morepen Laboratories Limited has announced the incorporation of a wholly owned subsidiary in Dubai, United Arab Emirates. The new entity, Morepen Labs – FZCO, has been officially registered on June 18, 2025, in the Free Zone jurisdiction of Dubai.
The company stated in a regulatory filing, “We are pleased to inform that ‘MOREPEN LABS – FZCO’, a wholly owned subsidiary of the company, has been incorporated today i.e., 18th June, 2025, in Free Zone, Dubai, United Arab Emirates.”
This move marks a significant step in Morepen’s international expansion strategy. The subsidiary has been established with an authorized capital of AED 50,000, comprising 5,000 ordinary shares of AED 10 each. Morepen will hold 100% ownership in this newly formed entity.
According to the company, “The incorporated entity being a wholly owned subsidiary, is a related party of the company. The promoter/ promoter group do not have any interest in the newly formed entity.”
Morepen Labs – FZCO will primarily focus on trading pharmaceuticals and medicines outside the UAE, aligning with the core business of its parent organization.
The filing further clarified that no governmental or regulatory approvals were required for this incorporation, and the acquisition was executed through cash consideration.
This expansion is expected to strengthen Morepen Laboratories’ global footprint and position the company for broader access to international markets in the pharmaceutical trade domain.
Ahmedabad Plane Crash